- Breast-Cancer Screening
[作者：Warner, E,期刊：New England Journal of Medicine, 页码：1025-1032 , 文章类型： Article，,卷期：2011年365-11]
- A healthy, 42-year-old white woman wants to discuss breast-cancer screening. She has no breast symptoms, had menarche at the age of 14 years, gave birth to her first child at the age of 26 years, is moderately overweight...
- A Field Trial to Assess a Blood-Stage Malaria Vaccine
[作者：Thera, MA; Doumbo, OK; Coulibaly, D; Laurens, MB; Ouattara, A; Kone, AK; Guindo, AB; Traore, K; Traore, I; Kouriba, B; Diallo, DA; Diarra, I; Daou, M; Dolo, A; Tolo, Y; Sissoko, MS; Niangaly, A; Sissoko, M; Takala-Harrison, S; Lyke, KE; Wu, YK; Blackwelder, WC; Godeaux, O; Vekemans, J; Dubois, MC; Ballou, WR; Cohen, J; Thompson, D; Dube, T; Soisson, L; Diggs, CL; House, B; Lanar, DE; Dutta, S; Heppner, DG; Plowe, CV,期刊：New England Journal of Medicine, 页码：1004-1013 , 文章类型： Article，,卷期：2011年365-11]
- Background Blood-stage malaria vaccines are intended to prevent clinical disease. The malaria vaccine FMP2.1/AS02(A), a recombinant protein based on apical membrane antigen 1 (AMA1) from the 3D7 strain of Plasmodium falc...
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
[作者：Sherman, KE; Flamm, SL; Afdhal, NH; Nelson, DR; Sulkowski, MS; Everson, GT; Fried, MW; Adler, M; Reesink, HW; Martin, M; Sankoh, AJ; Adda, N; Kauffman, RS; George, S; Wright, CI; Poordad, F,期刊：New England Journal of Medicine, 页码：1014-1024 , 文章类型： Article，,卷期：2011年365-11]
- Background Patients with chronic infection with hepatitis C virus (HCV) genotype 1 often need 48 weeks of peginterferon-ribavirin treatment for a sustained virologic response. We designed a noninferiority trial (noninfer...
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
[作者：Granger, CB; Alexander, JH; McMurray, JJV; Lopes, RD; Hylek, EM; Hanna, M; Al-Khalidi, HR; Ansell, J; Atar, D; Avezum, A; Bahit, MC; Diaz, R; Easton, JD; Ezekowitz, JA; Flaker, G; Garcia, D; Geraldes, M; Gersh, BJ; Golitsyn, S; Goto, S; Hermosillo, AG; Hohnloser, SH; Horowitz, J; Mohan, P; Jansky, P; Lewis, BS; Lopez-Sendon, JL; Pais, P; Parkhomenko, A; Verheugt, FWA; Zhu, J; Wallentin, L,期刊：New England Journal of Medicine, 页码：981-992 , 文章类型： Article，,卷期：2011年365-11]
- Background Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor that has been shown to red...
- Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis
[作者：Chimowitz, MI; Lynn, MJ; Derdeyn, CP; Turan, TN; Fiorella, D; Lane, BF; Janis, LS; Lutsep, HL; Barnwell, SL; Waters, MF; Hoh, BL; Hourihane, JM; Levy, EI; Alexandrov, AV; Harrigan, MR; Chiu, D; Klucznik, RP; Clark, JM; McDougall, CG; Johnson, MD; Pride, GL; Torbey, MT; Zaidat, OO; Rumboldt, Z; Cloft, HJ,期刊：New England Journal of Medicine, 页码：993-1003 , 文章类型： Article，,卷期：2011年365-11]
- Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke that is increasingly being treated with percutaneous transluminal angioplasty and stenting (PTAS) to prevent recurrent stroke. How...
|